Zhongzhu Healthcare Holding Co., Ltd. (600568)

Overview

Zhongzhu Healthcare Holding Co., Ltd, originally known as Zhongzhu Holding Co., Ltd before its rebranding in June 2016, stands as a prominent entity in China's pharmaceutical landscape since its inception in 1970. Positioned in Zhuhai, China, the company has carved a niche for itself through extensive involvement in the research, development, production, and sales of pharmaceutical drugs. It's remarkable how Zhongzhu Healthcare has expanded its horizons beyond pharmaceuticals, delving into realms like residential real estate development, capital market services, technology promotion and application services, medical services and devices, special equipment manufacturing, software and information technology services, hospital investment management, and leasing and business services. This multifaceted operation reflects the company's strategic diversification and commitment to contributing significantly across various sectors.

Products and Services

• Ophthalmology Drugs:

  Zhongzhu Healthcare has established a strong footing in the ophthalmology domain, offering a wide range of eye care products. This includes pearl eye drops, sodium cromoglycate eye drops solution, acyclovir eye drops, and hydroxybenzazole hydrochloride eye drops, among others. Their offerings cater to a variety of eye conditions, ensuring a comprehensive eye care solution.

• Pharmaceutical Tablets:

  The company also ventures into the production of pharmaceutical tablets such as acyclovir dispersible tablets and gatifloxacin tablets, highlighting its commitment towards addressing a broad spectrum of health concerns beyond ophthalmology.

• Medical Devices and Equipment:

  Zhongzhu Healthcare is not limited to pharmaceuticals; it also prides itself on the production and sales of cutting-edge medical devices and equipment. Noteworthy products in this category include the hepatest ultrasonic liver cirrhosis detector, infusion heater, and the Luna God full-body gamma knife. These innovations signify the company's venture into critical healthcare devices, aiming to improve diagnostic and therapeutic procedures.

• Residential Real Estate Development:

  Expanding its operational spectrum, the company has ventured into residential real estate development. This diversification showcases Zhongzhu Healthcare's strategic investments beyond its core pharmaceutical and medical device sectors.

• Capital Market Services:

  In addition to healthcare and real estate, Zhongzhu Healthcare offers capital market services. This diversification into the financial sector underscores the company’s adaptability and its push towards integrating healthcare with financial services.

• Non-Pharmaceutical Services:

  The company also excels in providing a range of services beyond pharmaceuticals, such as technology promotion and application service, medical services and devices, special equipment manufacturing, software and information technology service, hospital investment management, leasing, and business services. This wide array of services reflects Zhongzhu Healthcare's comprehensive approach to healthcare and technology.

• Research and Development:

  At the forefront of innovation, Zhongzhu Healthcare is actively involved in the research and development of new pharmaceuticals. Notable projects include Genistein capsule for women's menopausal syndrome, osteoporosis, and antitumor effects; and Leonurine sulfate tablets aimed at preventing and treating cardiovascular and cerebrovascular diseases and strokes. Such endeavors highlight the company's commitment to advancing medical science and offering novel healthcare solutions.